| PCMVX | VMVIX | PCMVX / VMVIX | |
| Total Expense Ratio | 1.07 | 0.19 | 563% |
| Annual Report Gross Expense Ratio | 1.09 | 0.19 | 574% |
| Fund Existence | 7 years | 19 years | - |
| Gain YTD | 7.484 | 12.058 | 62% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.34B | 32.6B | 7% |
| Annual Yield % from dividends | 1.02 | 2.02 | 51% |
| Returns for 1 year | -11.63 | 6.99 | -166% |
| Returns for 3 years | 1.28 | 30.03 | 4% |
| Returns for 5 years | 16.87 | 55.18 | 31% |
| Returns for 10 years | N/A | 118.02 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNAX | 78.05 | 0.75 | +0.97% |
| Janus Henderson Global Life Sciences A | |||
| RYAZX | 228.75 | 1.88 | +0.83% |
| Rydex S&P SmallCap 600 Pure Value H | |||
| SUSYX | 15.21 | 0.11 | +0.73% |
| SEI US Managed Volatility Y (SIMT) | |||
| RRGIX | 7.34 | 0.02 | +0.27% |
| DWS RREEF Global Real Estate Secc Inst | |||
| SXPAX | 56.30 | 0.12 | +0.21% |
| DWS S&P 500 Index A | |||